Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added new press releases dated 03.24.2026, 03.23.2026, and 03.20.2026 to the newsroom listings. Removed older items, including January 2026 and earlier press releases, to reflect updated content.
    Difference
    10%
    Check dated 2026-03-27T12:28:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added new press releases for 03/17/2026 and 03/19/2026, along with navigation enhancements (logo, search, Research and Research and Pipeline). Removed older webcast announcements and certain categories (Finance/Financial).
    Difference
    5%
    Check dated 2026-03-20T03:44:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a new press release entry for Pfizer’s Phase 2 study in atopic dermatitis dated 03.09.2026 (March 2026). Removed a prior press release about PADCEV™ plus Keytruda™ and removed 'Search' and 'Medicines' from the page navigation.
    Difference
    3%
    Check dated 2026-03-12T20:41:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added the 02.27.2026 press release 'PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer' under Medicines and Research and Pipeline. Removed the older 12.16.2025 press release 'Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance' and the Pfizer logo.
    Difference
    2%
    Check dated 2026-03-05T18:11:06.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    3%
    Check dated 2026-02-26T11:48:31.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added Medicines and Research and Pipeline categories and published the 02.17.2026 press release Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer. Removed the Research and Corporate categories and deleted the 12.09.2025 press release Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma.
    Difference
    2%
    Check dated 2026-02-19T04:25:02.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.